ECM
Endurant Capital Management Portfolio holdings
AUM
$17.4M
This Quarter Return
+1.8%
1 Year Return
+4.95%
3 Year Return
+16.8%
5 Year Return
+58.39%
10 Year Return
–
AUM
$326M
AUM Growth
+$326M
(-7.8%)
Cap. Flow
-$28.9M
Cap. Flow
% of AUM
-8.87%
Top 10 Holdings %
Top 10 Hldgs %
35.02%
Holding
109
New
17
Increased
26
Reduced
40
Closed
25
Top Buys
| 1 |
Sabra Healthcare REIT
SBRA
|
$12.2M |
| 2 |
Danaher
DHR
|
$11.8M |
| 3 |
Pediatrix Medical
MD
|
$7.61M |
| 4 |
Johnson & Johnson
JNJ
|
$7.35M |
| 5 |
TVTY
Tivity Health, Inc. Common Stock
TVTY
|
$6.25M |
Top Sells
| 1 |
Becton Dickinson
BDX
|
$8.29M |
| 2 |
UnitedHealth
UNH
|
$6.6M |
| 3 |
BCR
CR Bard Inc.
BCR
|
$6.29M |
| 4 |
iRhythm Technologies
IRTC
|
$6.29M |
| 5 |
Thermo Fisher Scientific
TMO
|
$6.24M |
Sector Composition
| 1 | Healthcare | 83.72% |
| 2 | Real Estate | 3.74% |
| 3 | Financials | 3% |
| 4 | Industrials | 0.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
DaVita
DVA
$9.85B
| $16.3M | 4.93% | 274,223 +88,726 | +48% | +$5.27M |
|
2
Biogen
BIIB
$19.4B
| $12.5M | 3.78% | 39,817 +8,185 | +26% | +$2.56M |
|
|
OXFD
3
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $12.3M | 3.72% | 731,509 -19,025 | -3% | -$320K |
|
|
4
Sabra Healthcare REIT
SBRA
$4.58B
| $12.2M | 3.7% | +556,330 | New | +$12.2M |
|
|
5
Danaher
DHR
$147B
| $11.8M | 3.58% | +137,865 | New | +$11.8M |
|
6
Abbott
ABT
$231B
| $11.3M | 3.43% | 211,983 -38,800 | -15% | -$2.07M |
|
|
7
Thermo Fisher Scientific
TMO
$186B
| $11.3M | 3.42% | 59,608 -33,000 | -36% | -$6.24M |
|
|
AET
8
DELISTED
Aetna Inc
AET
| $9.77M | 2.96% | 61,427 +5,000 | +9% | +$795K |
|
|
SHPG
9
DELISTED
Shire pic
SHPG
| $8.47M | 2.57% | 55,296 +2,300 | +4% | +$352K |
|
|
AGN
10
DELISTED
Allergan plc
AGN
| $8.3M | 2.51% | 40,477 +6,950 | +21% | +$1.42M |
|
|
TVTY
11
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $8.2M | 2.48% | 201,000 +153,300 | +321% | +$6.25M |
|
12
Pfizer
PFE
$141B
| $8.12M | 2.46% | 227,319 -4,081 | -2% | -$146K |
|
13
Universal Health Services
UHS
$11.6B
| $7.89M | 2.39% | 71,100 -39,300 | -36% | -$4.36M |
|
|
ESRX
14
DELISTED
Express Scripts Holding Company
ESRX
| $7.84M | 2.37% | 123,790 -5,700 | -4% | -$361K |
|
|
15
Pediatrix Medical
MD
$1.5B
| $7.61M | 2.3% | +176,400 | New | +$7.61M |
|
|
16
Johnson & Johnson
JNJ
$427B
| $7.35M | 2.23% | +56,500 | New | +$7.35M |
|
17
McKesson
MCK
$85.4B
| $7.04M | 2.13% | 45,800 -27,203 | -37% | -$4.18M |
|
18
Elevance Health
ELV
$71.8B
| $6.23M | 1.89% | 32,811 -16,404 | -33% | -$3.11M |
|
19
Boston Scientific
BSX
$156B
| $6.14M | 1.86% | 210,498 +82,800 | +65% | +$2.42M |
|
20
Cardinal Health
CAH
$35.5B
| $5.79M | 1.76% | 86,571 -14,120 | -14% | -$945K |
|
|
BCR
21
DELISTED
CR Bard Inc.
BCR
| $5.49M | 1.66% | 17,139 -19,622 | -53% | -$6.29M |
|
|
PTLA
22
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
| $5.43M | 1.64% | 100,400 +81,200 | +423% | +$4.39M |
|
23
VanEck Biotech ETF
BBH
$350M
| $5.2M | 1.58% | 38,799 -7,200 | -16% | -$966K |
|
|
NSTG
24
DELISTED
NanoString Technologies, Inc.
NSTG
| $4.77M | 1.45% | 295,260 -214,400 | -42% | -$3.46M |
|
|
CLVS
25
DELISTED
Clovis Oncology, Inc.
CLVS
| $4.68M | 1.42% | 56,750 +25,100 | +79% | +$2.07M |
|